Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Myoma Stories

2009-12-04 22:52:06

Boston University School of Medicine (BUSM) researchers at the Slone Epidemiology Center found that black women with high intake of dairy products have a reduced incidence of uterine leiomyomata (fibroids). This report, based on the Black Women's Health Study, appears in the current issue of the American Journal of Epidemiology. Uterine fibroids are benign tumors of the uterus and are two to three times more common among black women than white women. They are the primary indication for...

2009-07-29 10:21:34

A research article to be published on July 21, 2009 in the World Journal of Gastroenterology addresses this question. This research led by Professor Kim and his colleagues in Pusan National University, South Korea. They evaluated the EUS features of gastric GISTs in comparison with gastric leiomyomas, and tried to determine the EUS features that could predict the malignant potential of gastric GISTs according to the histological risk classification.In their study, to differentiate GISTs from...

2008-10-29 21:00:04

LAS VEGAS, Oct. 29 /PRNewswire/ -- At the annual meeting of the American Association of Gynecologic Laparoscopists (AAGL), ETHICON Women's Health & Urology today announced results of a seven-country study measuring the effects of uterine fibroids and associated symptoms on quality of life (QoL). Researchers found that one in five women suffer with symptomatic fibroids for more than 5 years before getting medical treatment. Further, despite diagnosis, more than one-third of women remain...

2008-09-09 09:00:09

ROCKLAND, Mass., Sept. 9 /PRNewswire/ -- Supermodel Beverly Johnson is on a mission to get women to Ask 4 questions and Tell 4 or more others about a health condition faced by up to 75 percent of all women in the U.S.(1): uterine fibroids. Although uterine fibroids are common, many women remain uninformed about this condition, and a majority wait up to a year before finding treatment, often despite pain, heavy bleeding and weight gain. Beverly did, and now she is sharing her story to ensure...

2008-08-19 09:00:16

PregLem has started an international Phase III clinical trial program for PGL4001 in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age. The program is composed of two separate Phase III clinical trials involving a total of 540 patients and being carried out in parallel in a total of 14 countries. Results of the Phase III trials are expected in 2010. The first trial (Pearl I) is a randomized, parallel group, double-blind,...

2008-08-19 03:00:13

Geneva, Switzerland, 19 August 2008 - PregLem SA, a Swiss biopharmaceutical company specialized in reproductive medicine, today announced the start of an international Phase III clinical trial program for PGL4001 (ulipristal) in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age. PGL4001, an orally active, selective progesterone receptor modulator, was shown in a previous Phase II study to be well...

2008-08-14 09:01:15

BioSphere Medical, Inc. (NASDAQ:BSMD)("BioSphere") - a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - today announced that in its August Practice Bulletin, the American College of Obstetricians and Gynecologists (ACOG) recommended uterine artery embolization (UAE) (also known as UFE) as an alternative to...

2006-02-02 15:15:00

By David Douglas NEW YORK (Reuters Health) - For the treatment of uterine fibroids, a minimally invasive procedure called uterine artery embolization (UAE) that shrinks fibroids by cutting off their blood supply is as effective as removing fibroids with an operation called myomectomy, a study confirms. But UAE offers the advantages of a speedier and less eventful recovery, the study shows. "As the evidence builds demonstrating uterine artery embolization's comparable efficacy to hysterectomy...